Success Stories: EB1-A Approval Obtained for an Adjunct Clinical Assistant Professor in Pharmacy from South Korea in Just 10 Days and Only Months Later Gets NIW Approval Too, Thanks to Premium Processing and Our Strong Case Preparation

Posted by wegreened on December 10, 2022 in EB1 Green Card, NIW, Medicine (Pharmaceutics, Pharmacology, Oncology, Pharmacognosy, Biomedical Engineering, Biomedicine)

Client’s Testimonial:

“I really appreciate your STRONG support for all processes.”

On April 1^st, 2022 and June 7^th, 2022, we received another EB-1A (Alien of Extraordinary Ability) and EB-2 NIW (National Interest Waiver) approval for an Adjunct Clinical Assistant Professor in the Field of Pharmacy (Approval Notice).

General Field: Pharmacy

Position at the Time of Case Filing: Adjunct Clinical Assistant Professor

Country of Origin: South Korea

State of Residence at the Time of Filing: Texas

Approval Notice Date: April 1^st, 2022 (EB-1A) and June 7^th, 2022 (NIW)

Processing Time: 10 days (EB-1A) (Premium Processing Requested) and 17 months, 9 days (NIW)

Case Summary:

Our firm North America Immigration Law Group aids people with various kinds of immigration services. This includes applying for and obtaining a range of visas such as EB1-A, EB2-NIW, O1A, O3, etc. We have been able to establish our name in the field over time and have over 25,000 case approvals under our belt. This means we have also gathered an immense amount of experience and knowledge of the ins and outs of the USCIS adjudication process.

So when we received a request from a South Korean client to file her NIW (National Interest Waiver) petition, our team was already certain about the path they needed to take. We began with the initial background check and moved ahead with countersigning the attorney-client agreement. This was followed by a thorough review of her academic and professional documents, which yielded the following data for her petition:

We found that she is one of the few leading complementary medicine, asthma, and obesity experts in pharmacy, and she has achieved a consistent and notable record of success and influence in this area of study, and she is especially well-known for the advancements she has contributed to effective and cost-effective treatment options for obese individuals, self-administered acupressure therapies, and symptom control in asthmatic patients.
We found that along with a Ph.D. in health and social pharmacy from the department of pharmaceutical policy and outcome research, she had published an enormous number of articles in scientific magazines well-known in her area of expertise. The count stood at 52 journal articles at the time of filing her EB1-A petition in 2022. At the same time, these articles were cited 635 times by peers in 56 countries making her the top 1% of the most cited author publishing in her field. The field has also recognized her authority by inviting her to review and evaluate the work of her peers no fewer than 12 times.
On the other hand, she has also received funding from two well-known institutions in South Korea, namely the Korea Institute of Oriental Medicine and the Korea Health Industry Development Institute, demonstrating that her work is recognized by reputed scientific organizations internationally.
Finally, our team helped her put together a list of 4 recommenders who provided letters of support recommending her services to the scientific community and the importance of her research for the United States. Two of these recommendations put forth the following about our client:

“[The client] has studied the management of obesity and its effects on these different factors and overall quality of life. Her work also seeks to improve the management of obesity and determine the best methods for its treatment. Seeing as she has markedly advanced ongoing efforts to mitigate the impact of one of the most common health disorders in the world, [the client’s] value as a researcher is plainly evident.”

“[The client’s] work has benefitted the field of pharmacy outside merely the realm of academic research. Her findings help refine self‐administered acupressure as a form of non-invasive and cost-effective CAM therapy, and one that helps patients manage symptoms of acute and chronic diseases independently. In this way, [the client’s] work is directly beneficial to the United States, and the significance of her research cannot be overstated.”

All of these factors went into making her NIW approval possible. At the same time, she also applied for an EB1-A (Alien of Extraordinary Ability) visa with our help in 2022. Since she had upgraded her case to premium processing, she received her approval only 10 days from filing. We are proud of having had the opportunity to work with her and our team wishes her the best in all future endeavors.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Sixty-four Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2012.01 - 2025.12)

Category	Approval or Refund^®		Approval or Refiling^TM
	Approval or Refund^®
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	42,047	99%	5,258	97%
EB1A	9,218	91%	4,534	86%
EB1B	1,488	98%	448	93%
Total	52,753	98%	10,240	92%